NIH grant awarded to Weill Cornell Medicine for fibrosis research

Weill Cornell Medicine researchers have received a grant to conduct an in-depth study of the mechanisms that cause scar tissue to form in the lung and kidney.

We Are Weill Cornell Medicine: Dr. Fernando Martinez

Dr. Fernando Martinez seized opportunities the U.S. afforded him; he’s dedicated his career to helping others, and has inspired his children to do the same.

Essentials

Cellular signaling pathway contributes to cancers

A signaling pathway in cells that regulates fat production could become a new target for cancer drugs, according to Weill Cornell Medicine researchers.

Binding molecule could improve injected radiation therapy

A group led by assistant professor Justin Wilson has developed a binding molecule that could improve targeted alpha-particle therapy - injected radiation treatment - for prostate cancer patients.

Symposium highlights Alzheimer’s research breakthroughs

Advances in scientific innovation are leading to powerful discoveries about Alzheimer’s and neurodegenerative diseases according to experts at the Appel Alzheimer’s Disease Research Institute Symposium.

New technique captures real-time movies of a molecular pump

Scientists have captured the first video recordings of a key protein whose function is essential to a deadly foodborne bacteria.

Chemical engineer turned CEO: ‘Wonderful time to be an entrepreneur’

Robert F. Smith '85, Cornell's Entrepreneur of the Year for 2017, spoke with engineering dean Lance Collins Nov. 3 in NYC.

ILR School forum: Tech promises jobs for people with disabilities

An ILR School forum in New York City focused on improving employment outcomes for people with disabilities in the tech sector.

Denise Young Smith is Cornell Tech’s next executive-in-residence

Denise Young Smith, Apple vice president of inclusion and diversity, will become executive-in-residence at Cornell Tech in January 2018.